Effect of voluntary running activity on mRNA expression of extracellular matrix genes in a mouse model of intervertebral disc degeneration.

Jang, Seon Ho; Lee, Seunghwan; Millecamps, Magali; Danco, Alexander; Kang, HyungMo; Grégoire, Stéphanie; Suzuki-Narita, Miyako; Stone, Laura S · JOR Spine · 2021

basic_science · Level V

Where this comes from

Abstract

Low back pain (LBP), a leading cause of global disability, is often associated with intervertebral disc degeneration (IDD). Exercise therapy is recommended for chronic LBP management and affects many tissues and organ systems. However, the ability of exercise to repair the extracellular matrix (ECM) in degenerating discs is unclear. The aims of the study were to examine mRNA expression of ECM structural components (collagen I, II, X, aggrecan) and regulators of matrix turnover (matrix metalloproteinases (MMP)-3, - 9, - 13, ADAMTS-4, - 5, TIMP1-4, CCN2) between age-matched (a) wild-type and secreted protein acidic and rich in cysteine (SPARC)-null, (b) sedentary and active, and (c) male and female mice. At 8 months of age, male and female SPARC-null and wild-type control mice received a home cage running wheel or a control, fixed wheel for 6 months. Deletion of the <i>SPARC</i> gene results in progressive IDD beginning at 2 to 4 months of age. Increased activity was confirmed, and qPCR was performed on excised lumbar discs. Male SPARC-null mice expressed less aggrecan mRNA than wild-type controls. After 6 months of running, collagen, <i>MMP3</i>, and <i>MMP13</i> expression was increased in male and <i>MMP3</i> was increased in female SPARC-null mice. Sex differences were observed in wild-type mice and in response to IDD and long-term running. Voluntary running results in changes in mRNA consistent with increased ECM turnover and disc regeneration. Improved disc ECM might contribute to the beneficial effects of exercise on LBP and may create an intradiscal environment hospitable to regenerative therapies. Sex-specific differences should be considered in the development of disc-targeting therapies.